Two weeks versus four weeks of antibiotic therapy after surgical drainage for native joint bacterial arthritis: a prospective, randomised, non-inferiority trial
- PMID: 30992295
- PMCID: PMC6691865
- DOI: 10.1136/annrheumdis-2019-215116
Two weeks versus four weeks of antibiotic therapy after surgical drainage for native joint bacterial arthritis: a prospective, randomised, non-inferiority trial
Abstract
Objective: The optimal duration of postsurgical antibiotic therapy for adult native joint bacterial arthritis remains unknown.
Methods: We conducted a prospective, unblinded, randomised, non-inferiority study comparing either 2 or 4 weeks of antibiotic therapy after surgical drainage of native joint bacterial arthritis in adults. Excluded were implant-related infections, episodes without surgical lavage and episodes with a follow-up of less than 2 months.
Results: We enrolled 154 cases: 77 in the 4-week arm and 77 in the 2-week arm. Median length of intravenous antibiotic treatment was 1 and 2 days, respectively. The median number of surgical lavages was 1 in both arms. Recurrence of infection was noted in three patients (2%): 1 in the 2-week arm (99% cure rate) and 2 in the 4-week arm (97% cure rate). There was no difference in the number of adverse events or sequelae between the study arms. Of the overall 154 arthritis cases, 99 concerned the hand and wrist, for which an additional subgroup analysis was performed. In this per-protocol subanalysis, we noted three recurrences: one in the 2-week arm (97 % cure); two in the 4-week arm (96 % cure) and witnessed sequelae in 50% in the 2-week arm versus 55% in the 4-week arm, of which five (13%) and six (13%) needed further interventions.
Conclusions: After initial surgical lavage for septic arthritis, 2 weeks of targeted antibiotic therapy is not inferior to 4 weeks regarding cure rate, adverse events or sequelae and leads to a significantly shorter hospital stay, at least for hand and wrist arthritis.
Trial registration number: NCT03615781.
Keywords: adverse events of antibiotics; antibiotic duration; native joint septic arthritis; randomized clinical trial; sequelae.
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Comment in
-
Response to: 'Less antibiotics but no inferior effect for bacterial arthritis' by Zhang et al.Ann Rheum Dis. 2020 Nov;79(11):e145. doi: 10.1136/annrheumdis-2019-215909. Epub 2019 Jul 5. Ann Rheum Dis. 2020. PMID: 31278134 No abstract available.
-
Is it currently reasonable to offer short, 14-day antibiotic therapies after a surgical synovectomy in native joint septic arthritis?Ann Rheum Dis. 2020 Nov;79(11):e146. doi: 10.1136/annrheumdis-2019-215887. Epub 2019 Jul 5. Ann Rheum Dis. 2020. PMID: 31278135 No abstract available.
-
Response to: 'Is it currently reasonable to offer short 14-day antibiotic therapies after a surgical synovectomy in native joint septic arthritis?' by Coiffier et al.Ann Rheum Dis. 2020 Nov;79(11):e147. doi: 10.1136/annrheumdis-2019-215905. Epub 2019 Jul 5. Ann Rheum Dis. 2020. PMID: 31278136 No abstract available.
-
Less antibiotics but no inferior effect for bacterial arthritis.Ann Rheum Dis. 2020 Nov;79(11):e144. doi: 10.1136/annrheumdis-2019-215682. Epub 2019 Jul 5. Ann Rheum Dis. 2020. PMID: 31278137 No abstract available.
-
Response to: 'Short duration antibiotic therapy for native joint arthritis cause by Neisseria infection?' by Durcours et al.Ann Rheum Dis. 2022 Nov;81(11):e231. doi: 10.1136/annrheumdis-2020-218882. Epub 2020 Sep 28. Ann Rheum Dis. 2022. PMID: 32988834 No abstract available.
-
Short duration antibiotic therapy for native joint arthritis caused by Neisseria infection?Ann Rheum Dis. 2022 Nov;81(11):e230. doi: 10.1136/annrheumdis-2020-218835. Epub 2020 Sep 28. Ann Rheum Dis. 2022. PMID: 32988840 No abstract available.
References
-
- Debrach AC, Lazarou I, Gabay C, et al. . Management of septic arthritis. Rev Med Suisse 2018;14:516–21. - PubMed
